MOTIVATE AF Motivational Support for Patients With Atrial Fibrillation to Promote Weight Loss
Condition: Atrial Fibrillation Interventions: Other: Weight Watchers; Other: Slimming world; Other: Leeds 'One You'; Other: NHS Choices; Other: 5:2 diet; Other: Individuals own personal plan Sponsor: The Leeds Teaching Hospitals NHS Trust Not yet recruiting
Authors: Shoji M, Suzuki S, Otsuka T, Arita T, Yagi N, Semba H, Kano H, Matsuno S, Kato Y, Uejima T, Oikawa Y, Matsuhama M, Yajima J, Yamashita T Abstract Objective The pharmacodynamic effect of warfarin varies among individuals, and its maintenance dose is widely distributed. Although many formulae for predicting the maintenance dose of warfarin have been developed, most of them are complex and not in practical use. Methods and Materials Among 12,738 new patients visiting the Cardiovascular Institute between 2004 and 2009, we identified 127 patients (66.6±8.8 years, 89 men) with atrial fibrillation for whom...
We examined trends of SDD, and using 2:1 propensity matching, we assessed 30-day rates of readmission, mortality and total costs at 30 days.ResultsOf 21,261 PCIs from 67 sites, 728 were SDD (3.9% of overall cohort). The rate of SDD increased from 1.6% in 2008 to 9.7% in 2016 (P
Sensors, Vol. 19, Pages 3969: Enabling Heart Self-Monitoring for All and for AAL—Portable Device within a Complete Telemedicine System Sensors doi: 10.3390/s19183969 Authors: Andrés-Lorenzo Bleda Francisco-Manuel Melgarejo-Meseguer Francisco-Javier Gimeno-Blanes Arcadi García-Alberola José Luis Rojo-Álvarez Javier Corral Ricardo Ruiz Rafael Maestre-Ferriz During the last decades there has been a rapidly growing elderly population and the number of patients with chronic heart-related diseases has exploded. Many of them (such as those with congestive heart failure or so...
AbstractAtrial high rate episodes (AHREs), also termed, subclinical atrial tachyarrhythmias or subclinical atrial fibrillation (AF) are an important cardiovascular condition. Advancement in implantable cardiac devices such as pacemakers or internal cardiac defibrillators has enabled the continuous assessment of atrial tachyarrhythmias in patients with an atrial lead. Patients with device-detected AHREs are at an elevated risk of stroke and may have unmet anticoagulation needs. While the benefits of oral anticoagulation for stroke prevention in patients with clinical AF are well recognised, it is not known whether the same ...
Conclusions The presence of comorbidities was linked to NOAC use over vitamin K antagonist, which is different from prescription factor studies in other countries and requires further study.
ConclusionsThe CHA2DS2-VASc score has relatively good performance in predicting POAF after cardiac surgery and may help identify the patients at high risk of POAF.
Authors: De Vecchis R Abstract Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiarrhythmic drug had been tested. PMID: 31505912 [PubMed - in process]
ConclusionThe overall estimated incidence of AF and recurrent AF during pregnancy is as high as 2.2% and 39.2%, respectively. AF during pregnancy may result in poor maternal and fetal outcomes.
This study compared the risk of stroke and major bleeding with NOACs vs. warfarin among patients 80 years of age and older with nonvalvular atrial fibrillation.Journal of the American Geriatrics Society
The prevalence of atrial fibrillation (AF) has been increasing in aging societies. The prognostic impact of AF associated with worsening heart failure (HF) remains obscure.